Saikat Nandi

Saikat Nandi, listed as chief executive, appears in our data through filings on Oryzon Genomics, S.A. shares, published by CNMV. Over a trading history stretching from 8 July 2022 to 1 February 2023, the count stands at 2 filings.

The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

The record was last updated on 6 February 2023 with a transaction (€30k) in Oryzon Genomics, S.A. Source: insider filings from CNMV. Past trades are no guide to future returns.